<?xml version="1.0" encoding="UTF-8"?>
<p id="Par153">There is a constant search for novel drugs in the treatment of viral-related CNS infections and a detailed discussion falls beyond the scope of this chapter, but there are a few interesting ideas that deserve mention. Nucleotidyltransferase superfamily enzyme inhibitors have been identified as a potential novel treatment for HSV infections and suppress the replication of the virus [
 <xref ref-type="bibr" rid="CR50">50</xref>]. Significant advances in gene editing have been made and include three possible strategies in antiviral drug development: zinc-finger nucleases, transcription activator-like effector nucleases and clustered regulatory interspaced short palindromic repeat-associated nine systems [
 <xref ref-type="bibr" rid="CR51">51</xref>].
</p>
